Company Filing History:
Years Active: 2024
Title: Kegan Moneghetti: Innovator in Glycemic Dysregulation and Cardiovascular Disease
Introduction
Kegan Moneghetti is a notable inventor based in Stanford, CA (US). He has made significant contributions to the field of medical technology, particularly in the evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease. His innovative approaches aim to improve patient outcomes through advanced methodologies.
Latest Patents
Kegan Moneghetti holds a patent titled "Methods for evaluation and treatment of glycemic dysregulation and atherosclerotic cardiovascular disease and applications thereof." This patent describes methods to compute glycemia tests and applications thereof. Additionally, it outlines methods to compute the risk of atherosclerotic cardiovascular disease. The systems he developed utilize analyte measurements to determine glycemic status or cardiovascular disease risk, which can serve as a basis for treating individuals. He has 1 patent to his name.
Career Highlights
Moneghetti is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovations. His work is pivotal in bridging the gap between technology and healthcare, providing new solutions for managing chronic diseases.
Collaborations
Kegan Moneghetti collaborates with esteemed colleagues such as Sophia Miryam Schüssler-Fiorenza Rose and Kevin Contrepois. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Kegan Moneghetti is a prominent figure in the realm of medical innovation, focusing on critical health issues such as glycemic dysregulation and cardiovascular disease. His contributions through patents and collaborations are paving the way for advancements in patient care and treatment methodologies.